FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372546009: Cytoprotective agent (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1197839018 Cytoprotective agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211077014 Cytoprotective agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1197839018 Cytoprotective agent (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1197839018 Cytoprotective agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211077014 Cytoprotective agent en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1211077014 Cytoprotective agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    189201000077111 agent cytoprotecteur fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
    189201000077111 agent cytoprotecteur fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    agent cytoprotecteur Is a Antineoplastic agent (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Dexrazoxane Is a False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Mitotane Is a False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Resveratrol Is a False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Cytoprotective agent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Dexrazoxane hydrochloride 250mg/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Dexrazoxane hydrochloride 500mg/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Mesna 400mg/amp injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Mesna 1g injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Mesna 200mg injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Amifostine Is a False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Mesna 1g injection solution 20mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Mesna 200mg injection solution 2mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Mesna 1g injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Mesna 400mg/amp injection solution 4mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely razoxane 125 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Razoxane-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Mesna-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Mesna 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Mesna 600 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Mesna 100mg/mL injection solution 4mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Mesna 100mg/mL injection solution 10mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)
    Dexrazoxane-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False agent cytoprotecteur Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    Back to Start